Cloud Banner

Healthcare

Image

Global Neurosurgery Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Published Report
  • Sep 2022
  • Global
  • 350 Pages
  • No of Tables: 55
  • No of Figures: 69

Global Neurosurgery Market, By Product Type (Neurosurgery Devices, Neurosurgery Software, Consumables), Application (Aneurysms, Arteriovenous Malformation (AVM), Brain Tumors, Carotid Artery Blockage/Stenosis, Cerebrovascular Surgery, Cortical Mapping, Epilepsy, Functional Neurosurgery, Intraoperative Angiography, Parkinson's Disease and Tremors, Peripheral Nerve Surgery, Pituitary Tumors, Radiosurgery, Skull Base Surgery, Spine Surgery, Stereotactic Neurosurgery, Trauma Surgery, Trigeminal Neuralgia, Others), Age Group (Pediatric, Adult, Geriatric), End User (Hospitals, Neurosurgery Centers, Research Centers, Ambulatory Surgical Centers, Others), Distribution Channel (Direct Tender, Third Party Distributors, Others) Industry Trends and Forecast to 2029

Neurosurgery Market

Neurosurgery Market Analysis and Insights

Technological innovation within healthcare may be defined as the introduction of a new technology that initiates a change in clinical practice. Neurosurgery is a particularly technologically intensive surgical discipline, and new technologies have preceded many of the major advances in operative neurosurgical techniques. The present focus is on developing minimally-invasive devices that could decrease the probability of complications during operative sessions. With the introduction of minimally-invasive techniques, doctors are using highly specialized surgical instruments such as power tools, neurovascular embolization devices, and radiosurgery systems such as gamma-knife.

Neurosurgery Market

Neurosurgery Market

In addition, a set of new factors, such as enhanced regulatory standards and an increasing incidence of neurological diseases, has led to an increase in the adoption of advanced treatment protocols and the assumption that such therapies will be available more widely. This has increased industry and government demand for zero deviations, which has driven the demand for neurosurgical services, and an increase in cross-industry alliances and collaborations is a major factor expected to boost the neurosurgery market. However, the higher costs involved in neuro endoscopy equipment and procedures, along with the lack of trained professionals, may restrain the market growth in the forecast period.

Data Bridge Market Research analyzes that the global neurosurgery market is expected to reach the value of USD 20,679.72 million by 2029, at a CAGR of 14.2% during the forecast period. "Product type" accounts for the largest type segment in the market due to the increasing patient population globally. This market report also covers pricing analysis, patent analysis, and technological advancements in depth.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019-2014)

Quantitative Units

Revenue in USD Million, Volumes in Units, Pricing in USD

Segments Covered

Global neurosurgery market, By Product Type (neurosurgery devices, neurosurgery software, consumables), Application (aneurisms, arteriovenus malformation (AVM), brain tumors, carotid artery blockage/stenosis,  cerebrovascular surgery, cortical mapping, epilepsy, functional neurosurgery, intraoperative angiography, Parkinson's disease and tremors, peripheral nerve surgery, pituitary tumors, radiosurgery, skull base surgery, spine surgery, stereotactic neurosurgery, trauma surgery, trigeminal neuralgia, others), Age Group (pediatric, adult, geriatric), End User (hospitals, neurosurgery centers, research centers, ambulatory surgical centers, others) Distribution Channel (direct tender, third party distributors, others)

Countries Covered

U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and the rest of Europe, China, Japan, India, South Korea, Singapore, Thailand, Malaysia, Australia, Philippines, Indonesia and rest of Asia-Pacific, UAE, Israel, South Africa, Saudi Arabia, Egypt and rest of the Middle East and Africa, Brazil, Argentina and the rest of South America

Market Players Covered

Medtronic, Abbott, Boston Scientific Corporation or its affiliates, Elekta, ALEVA NEUROTHERAPEUTICS, Machida Endoscope Co., Ltd., Brainlab AG, adeor medical AG., LivaNova PLC, B. Braun SE, Optofine Instruments Pvt. Ltd., Wallaby Medical, Terumo Medical Corporation, NEVRO CORP., Integra LifeSciences, Stryker, Penumbra, Inc., KARL STORZ SE & Co. KG, Nalu Medical, Inc., Renishaw plc., Synapse Biomedical Inc., EMS Handels Gesellschaft mbH, Inomed Medizintechnik GmbH, BIOINDUCTION, ANT Neuro, Advantis Medical Imaging, and Leica Microsystems among others

Global Neurosurgery Market Definition

The neurological conditions include dementia, headache disorders, neuro-infections, and multiple sclerosis, traumatic brain injuries, pain associated with neurological disorders, neurological disorders associated with malnutrition, stroke, epilepsy, and Parkinson's disease. These disorders are fatal and cannot be cured by therapeutics. Some of the neurosurgery devices are neuro-endoscopes, stereotactic systems, catheters, pacemakers, single- and dual-chamber defibrillators, and implantable cardioverter defibrillators among others, that are used in a variety of neurosurgical procedures. Neurosurgery aids in the diagnosis of patients who have brain tumors, spinal cord injuries brought by accidents, neck and back discomfort, and abnormal spinal fluid movement. Around 7 to 10 million people worldwide suffer from Parkinson's disease. Neurological illness is one of the main causes of morbidity and disability worldwide. During the forecast period, technological developments in neurosurgery are anticipated to drive the market. The rise in incidences and prevalence of neurological conditions within the population and the advantage of neurosurgery over other conventional surgeries are expected to boost the growth of the neurosurgery market across the globe. In addition, advances in neurological surgeries such as 3-dimension reconstruction for brain tumor surgery, X-knife radiosurgery for brain lesions, MRI for brain tumors, and surgery under local anesthesia for brain tumors are anticipated to provide lucrative opportunities for the growth of the neurosurgery market.

Global Neurosurgery Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:    

Drivers

  • Technological advancement in neurosurgery

Since the beginning of modern neurosurgery, technological advancements have paved the way for a more thorough and enhanced understanding of cerebral form and function to more effectively treat complex pathologies affecting patients. Technological advancements brought a transition from conventional equipment toward energy-efficient equipment based on novel technology. Several cutting-edge techniques help neurosurgeries quite easily. Neurosurgery is a particularly technologically intensive surgical discipline, and new technologies have preceded many of the major advances in operative neurosurgical techniques. Image guidance and neuromodulation devices demonstrated a highly correlated rapid rise in patents and publications, suggesting they are areas of technology expansion which is expected to boost the market growth.

With the growth in the prevalence of neurological conditions, the demand for neurosurgery is also increasing. The market is expected to grow in the forecast period.

Moreover, the adoption of endoscopic techniques' is a significant market advancement. Additionally, recovery time is shorter in neurosurgeries. Thus, all these factors are expected to act as drivers for market growth.

  • Rising prevalence of neurological conditions

The World Health Organization (WHO) focuses on research in areas that are important for public health promotion. Recently, WHO has been particularly interested in frequent and disabling neurological disorders with a high burden on the world. Neurological disorders occur among all age groups and different geographical regions. They significantly contribute to morbidity and mortality around the world. The neurological burden of disease is expected to grow exponentially in low- and middle-income countries (LMICs) in the next decade.

The rising prevalence of neurological conditions such as transnasal hemorrhage, intracerebral hemorrhage (ICH), traumatic brain injury, chronic pain, depression, and Parkinson's is expected to drive market growth.

Thus, increasing neurological disorders such as transnasal hemorrhage and intracerebral hemorrhage (ICH) are fueling market growth. Neurological conditions have become a major public health crisis which is expected to boost the growth of the global neurosurgery market.

Restraint

  • The high cost associated with neurosurgeries and equipment

A significant increase in the cost of neurosurgical products has been observed in recent years, which end users such as hospitals and neurosurgical centers have to incur. Products such as neurovascular embolization devices, neurovascular coiling devices, and neuroendoscopes are quite costly. Manufacturers are also giving more resources to research and development to introduce cost-effective and advanced technology. Some complex neurosurgeries require extensive time as well as effort, and they are also quite risky. These complex procedures need advanced techniques and skills, and because of this, the cost of equipment and neurosurgeries increases. The maintenance of such facilities and continuous requirement of power supply add up to the cost of the surgeries. Decompressive craniectomy for traumatic brain injury (TBI) is an expensive procedure that is also associated with high morbidity and mortality.

The cost associated with neurosurgery procedures is quite high, which is expected to act as a restrain for the market growth.

Neurosurgery Market

Opportunity

  • Rising awareness about neurological disorders

With the rising global population, a large portion of the geriatric section is getting affected by neurological disorders such as epilepsy, Parkinson's disease, stroke, brain tumor, dementia, and multiple sclerosis, among others. So, understanding neurological disorders is important, and awareness about neurological conditions can lead to seeking medical attention, which results in proper diagnosis and effective treatment. All neurological disorders account for 82.8%. The massive fold increases the burden of neurological disorders that can be attributed to a lack of awareness about neurological disorders and treatment, which lead to delayed detection, and lack of access to quality healthcare and rehabilitation centers. Rising healthcare programs and increasing funding from governments and public healthcare agencies help reduce the burden of neurological disorders and develop neurological products that act in favor of market growth.

Rising awareness about neurological disorders is beneficial for the neurosurgery market. In most regions, many governmental and non-governmental are carry some awareness programs for the early detection of neurological conditions.

Challenge

  • Alternative treatments for neurological disease

Drug therapies are the first line of treatment for the treatment of neurological conditions. Neurosurgical procedures are opted only if non-surgical treatments are not effective. Complementary and alternative treatments are increasingly employed to supplement neurosurgical treatment in neurosurgery. This includes acupuncture, naturopathic medicine, chiropractic treatment, and ayurvedic medicine among others. More recently, doctors have become increasingly receptive to the use of alternative treatments, and scientific studies on the safety and effectiveness of complementary and alternative options are taken through the national institutes of health, which may act as a challenge to the growth of the neurosurgery market.

Thus, alternative treatment options are expected to offer significant challenges for the global neurosurgical market. 

Post-COVID-19 Impact on Global Neurosurgery Market

The COVID-19 outbreak had a drastic effect on global healthcare, with the U.K., U.S., China, South Africa, and others, amongst the countries most severely impacted. The pandemic has had a negative impact on the neurosurgery market growth on account of the temporary halt in research activities in this field, coupled with the low influx of patients in hospitals and diagnostic centers. Moreover, the impact of COVID-19 pandemic on neurosurgical products delivery is challenging the neurosurgeons for getting delivery of surgical products.

Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple R&D activities and product launches, and strategic partnerships to improve the technology in the neurosurgery market.

Recent Developments

  • In March 2022, Medtronic, a leader in healthcare technology, announced their first patient implants in the TITAN 2 pivotal study that evaluated the safety and efficacy of Medtronic's investigational implantable tibial neuromodulation (TNM) device in people with overactive bladder (OAB). Implantable TNM has the potential to give relief to millions who suffer from bladder incontinence through a new approach that provides greater convenience and more options for physicians and patients. This will help the company to evaluate the safety and efficacy of its products
  • In April 2022, Abbott announced that it had launched an upgraded version of its NeuroSphere myPath digital health app with enhanced functionality that will help doctors more closely track their patients as they trial Abbott neurostimulation devices to address their chronic pain. This upgrade is part of Abbott's commitment to connected care technology and is intended to put people in control of their health and facilitate better communication with their doctors. This has helped the company to enhance its product use by launching the app
  • In April 2022, Boston Scientific Corporation or its affiliates announced it had received U.S. Food and Drug Administration (FDA) approval for its latest image-guided programming software, Vercise Neural Navigator, with STIMVIEW XT. Developed in collaboration with Brainlab AG, a leading software-driven medical technology company. This has helped the company to expand its product portfolio
  • In October 2020, Accuray Incorporated announced a collaboration with Brainlab AG, a market leader in digital surgery and precision radiotherapy that will enhance and expand the Accuray CyberKnife treatment platform for the neuro-radiosurgery market. Both companies are partnering to provide the neuro-radiosurgery community with access to Brainlab Elements planning software, which will provide contouring capabilities optimized for neurosurgeons. This has helped the company to expand its business

Global Neurosurgery Market Scope

The global neurosurgery market is segmented into product type, application, age group, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

By Product Type

  • Neurosurgery devices
  • Neurosurgery software
  • Consumables

On the basis of product type, the global neurosurgery market is segmented into neurosurgery devices, neurosurgery software, and consumables.

By Application

  • Aneurysms
  • Arteriovenous malformation (AVM)
  • Brain tumors
  • Carotid artery blockage/stenosis
  • Cerebrovascular surgery
  • Cortical mapping
  • Epilepsy
  • Functional neurosurgery
  • Intraoperative angiography
  • Parkinson's disease and tremors
  • Peripheral nerve surgery
  • Pituitary tumors
  • Radiosurgery
  • Skull base surgery
  • Spine surgery
  • Stereotactic neurosurgery
  • Trauma surgery
  • Trigeminal neuralgia
  • Others

On the basis of application, the global neurosurgery market is segmented into aneurysms, arteriovenous malformation (AVM), brain tumors, carotid artery blockage/stenosis, cerebrovascular surgery, cortical mapping, epilepsy, functional neurosurgery, intraoperative angiography, Parkinson's disease and tremors, peripheral nerve surgery, pituitary tumors, radiosurgery, skull base surgery, spine surgery, stereotactic neurosurgery, trauma surgery, trigeminal neuralgia, others.

By Age Group

  • Pediatric
  • Adult
  • Geriatric

On the basis of end user, the global neurosurgery market is segmented into pediatric, adult, and geriatric.

By End User

  • Hospitals
  • Research centers
  • Neurosurgery centers
  • Ambulatory surgical centers (ASCS)
  • Others

On the basis of end user, the global neurosurgery market is segmented into hospitals, neurosurgery centers, research centers, ambulatory surgical centers, and others.

By Distribution Channel

  • Direct tender
  • Third party distributors
  • Others

Neurosurgery Market

On the basis of distribution channel, the global neurosurgery market is segmented into direct tender, third party distributors, and others.

Global Neurosurgery Market Regional Analysis/Insights

The global neurosurgery market is analyzed, and market size information is provided by product type, application, age group, end user, and distribution channel.

The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and the rest of Europe, China, Japan, India, South Korea, Singapore, Thailand, Malaysia, Australia, Philippines, Indonesia, and rest of Asia-Pacific, U.A.E., Israel, South Africa, Saudi Arabia, Egypt, and rest of the Middle East and Africa, Brazil, Argentina, and the rest of South America.

In 2022, North America is expected to dominate the global neurosurgery market due to the presence of key market players in the largest consumer market with high GDP. The U.S. is expected to grow due to the rise in technological advancement in neurosurgical equipment. The increasing investment in R&D and the increasing adoption of neurosurgery as an option for the formulation of treatment regimens are expected to boost market growth. The U.S. dominates North America region due to the strong presence of advanced technology providers such as Terumo Medical Corporation, NEVRO CORP., Integra LifeSciences, Stryker, and others. The U.K. is expected to dominate the Europe region due to the increasing demand from emerging markets and the expansion of healthcare industries. China is expected to dominate the Asia-Pacific region due to an increase in healthcare expenditure.

Neurosurgery Market

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Global Neurosurgery Market Share Analysis

The global neurosurgery market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in R&D, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breath, application dominance, technology lifeline curve. The above data points provided are only related to the company's focus on the global neurosurgery market.

Some of the major players operating in the global neurosurgery market are Medtronic, Abbott, Boston Scientific Corporation or its affiliates, Elekta, ALEVA NEUROTHERAPEUTICS, Machida Endoscope Co., Ltd., Brainlab AG, adeor medical AG., LivaNova PLC, B. Braun SE, Optofine Instruments Pvt. Ltd., Wallaby Medical, Terumo Medical Corporation, NEVRO CORP., Integra LifeSciences, Stryker, Penumbra, Inc., KARL STORZ SE & Co. KG, Nalu Medical, Inc., Renishaw plc., Synapse Biomedical Inc., EMS Handels Gesellschaft mbH, Inomed Medizintechnik GmbH, BIOINDUCTION, ANT Neuro, Advantis Medical Imaging, and Leica Microsystems among others.

Research Methodology: Global neurosurgery market

Data collection and base year analysis are done using data collection modules with large sample sizes. The market data is analyzed and estimated using market statistical and coherent models. In addition, market share analysis and key trend analysis are the major success factors in the market report. The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Global vs. Regional, and Vendor Share Analysis. Please request an analyst call in case of further inquiry.


SKU-

TABLE 1 GLOBAL NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 2 GLOBAL NEUROSURGERY DEVICES IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 GLOBAL NEUROSURGERY DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 4 GLOBAL NEUROMODULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 5 GLOBAL INTERNAL NEUROMODULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 6 GLOBAL SPINAL CORD STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 7 GLOBAL DEEP BRAIN STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 8 GLOBAL SACRAL NERVE STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 9 GLOBAL VAGUS NERVE STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 10 GLOBAL GASTRIC ELECTRICAL STIMULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 11 GLOBAL EXTERNAL NEUROMODULATION DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 12 GLOBAL NEURO-INTERVENTIONAL DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 13 GLOBAL EMBOLIZATION COILS IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 14 GLOBAL NEUROVASCULAR THROMBECTOMY IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 15 GLOBAL NEUROSURGICAL POWER TOOLS IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 16 GLOBAL DRILL IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 17 GLOBAL CEREBROSPINAL FLUID (CSF) MANAGEMENT DEVICES IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 18 GLOBAL NEUROSURGERY SOFTWARE IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 GLOBAL NEUROSURGERY SOFTWARE IN NEUROSURGERY MARKET, BY PRODUCT TYPE, 2020-2029 (USD MILLION)

TABLE 20 GLOBAL CONSUMABLES IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 GLOBAL NEUROSURGERY MARKET, BY AGE GROUP, 2020-2029 (USD MILLION)

TABLE 22 GLOBAL PEDIATRIC IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 GLOBAL ADULT IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 24 GLOBAL GERIATRIC IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 GLOBAL NEUROSURGERY MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 26 GLOBAL BRAIN TUMORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 GLOBAL TRAUMA SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 28 GLOBAL SPINE SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 GLOBAL PARKINSON’S DISEASE AND TREMORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 GLOBAL PERIPHERAL NERVE SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 GLOBAL EPILEPSY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 32 GLOBAL FUNCTIONAL NEUROSURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 GLOBAL CAROTID ARTERY BLOCKAGE/STENOSIS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 GLOBAL INTERAOPERATIVE ANGIOGRAPHY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 GLOBAL CEREBROVASCULAR SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 GLOBAL ANEURYSMS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 37 GLOBAL PITUITARY TUMORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 GLOBAL RADIOSURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 39 GLOBAL STEREOTACTIC NEUROSURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 GLOBAL CORTICAL MAPPING IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 41 GLOBAL ARTERIOVENOUS MALFUNCTION (AVM) IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 42 GLOBAL SKULL BASE SURGERY IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 43 GLOBAL TRIGEMINAL NEURALGIA IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 44 GLOBAL OTHERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 45 GLOBAL NEUROSURGERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 46 GLOBAL HOSPITALS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 47 GLOBAL HOSPITALS IN NEUROSURGERY MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 48 GLOBAL RESEARCH CENTERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 49 GLOBAL NEUROSURGERY CENTERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 50 GLOBAL AMBULATORY SURGICAL CENTERS (ASCS) IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 51 GLOBAL OTHERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 52 GLOBAL NEUROSURGERY MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 53 GLOBAL DIRECT TENDER IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 54 GLOBAL THIRD PARTY DISTRIBUTORS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 55 GLOBAL OTHERS IN NEUROSURGERY MARKET, BY REGION, 2020-2029 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The neurosurgery market size will be worth USD 20,679.72 million by 2029.
The growth rate of the neurosurgery market is USD 20,679.72 million by 2029.
The major companies in the neurosurgery market are Medtronic (Ireland), B. Braun Melsungen AG (Germany), Stryker (U.S.), Brainlab AG (Germany), Integra LifeSciences (U.S.), Scopis GmbH (Germany), Boston Scientific Corporation (U.S.), etc
Product type, application, age group, end user, and distribution channel are the factors on which the neurosurgery market research is based.
Technological advancement in neurosurgery & rising prevalence of neurological conditions are the growth drivers of the neurosurgery market.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials